The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Nearly 200 participants from 50 Unani Academia and Council participated
Report highlights significant improvements in adolescent well-being in India
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Enhanced collaboration under the Memorandum of Cooperation (MoC) between India and Japan in medical product regulations
Subscribe To Our Newsletter & Stay Updated
